stella
Coronary Artery DiseaseJanuary 2024Summary reviewed November 2026

Glutamate Infusion Cut Acute Kidney Injury Risk in Half After Heart Surgery

Patients without diabetes who received a glutamate infusion during heart bypass surgery had roughly half the risk of acute kidney injury compared to those who got saline. Kidney injury after cardiac surgery is common and serious, and this treatment may help prevent it.

What the trial was testing

The GLUTAMICS II enrolled 321 patients with coronary artery disease. The study was sponsored by University Hospital, Linkoeping and tracked outcomes across the full group of patients who matched the trial's eligibility profile.

It was a large trial designed to confirm whether the treatment works well enough for wider use. Trials at this stage are designed to produce evidence regulators and physicians can act on — not just observations to follow up later.

What the results showed

Glutamate infusion cut acute kidney injury risk in half after bypass surgery in non-diabetic patients.

JAMA network open · 2024 · NCT02592824

These findings — that glutamate infusion reduced acute kidney injury risk compared to saline control — were published in the JAMA network open and represent the headline result of the study.

Researchers tracked outcomes across 321 patients enrolled in the trial. The result was consistent enough across the group that the team felt confident reporting it.

What this means for patients

For patients with coronary artery disease, this result changes the calculus on what to ask their care team about. Whether it changes day-to-day care depends on factors like disease subtype, prior treatments, and where the patient is in their care journey.

What you can do now

If you're facing bypass surgery and don't have diabetes, this glutamate treatment may protect your kidneys from injury—a major complication after heart surgery. The treatment is given as an IV during and shortly after surgery. While these results are promising, larger studies are still needed before this becomes standard practice.

Eligibility for the treatments mentioned above depends on specific test results and clinical history. Bring this summary, the trial name, and your most recent labs or pathology report to your next visit.

Open coronary artery disease trials

RecruitingObservational study

Progress Complication

Coronary angiography and percutaneous coronary intervention (PCI) is often performed in patients with ischemic heart disease. The safety of PCI has improved with new devices and strategies, but complications still occur, especially during complex procedures. The objectives of this multi-center observational registry are to examine frequency of complications occuring during cardiac catheterization and PCI, examine procedural strategies utilized for complication management, and evaluate the clinical outcomes (both immediate and during follow-up.)

Minneapolis, Minnesota, United States
RecruitingInterventional study

ULTIMATE Study (Carotid Ultrasound Vs CT Coronary Calcium Scoring to Reclassify Symptomatic Patients With Chronic Coronary Syndrome)

* Chest pain is one of the most common symptoms of heart disease. This could be due to narrowing in heart's blood vessels, which needs to be investigated. * Currently, people with a low risk of narrowing of heart vessels usually have a CT scan of the heart first. This scan is good at identifying those who do not have significant narrowing. However, the scan has some drawbacks, such as exposure to a small amount of radiation. * We are exploring if ultrasound of the neck vessels might give us similar kind of information as the CT scan. * You will be asked to attend the hospital for one visit to have an ultrasound scan of your neck. * The findings of your neck vessels will be compared with the CT scan of your heart vessels to see if there is a similarity.

Harrow, United Kingdom